Reforming 340B to Promote Program Integrity and Better Serve Vulnerable Populations

A position paper from ACP outlining recommendations to reform the 340B Drug Pricing Program, which allows health care safety-net settings to purchase prescription drugs at deep discounts. To strengthen the 340B Program and ensure it is best serving its intended audience, reforms are needed within the program to promote transparency in how drug savings are reinvested into patient care and mandate demonstrated benefit to low-income and uninsured populations.

A position paper from ACP outlining recommendations to reform the 340B Drug Pricing Program, which allows health care safety-net settings to purchase prescription drugs at deep discounts. To strengthen the 340B Program and ensure it is best serving its intended audience, reforms are needed within the program to promote transparency in how drug savings are reinvested into patient care and mandate demonstrated benefit to low-income and uninsured populations.

Laura Baldwin

prescription drugs; 340B; affordability; drug prices; 340B drug pricing program; pharmacies; disparities; Medicaid; HRSA

Tue, 07/21/2026 - 10:50 AM EDT

Tue, 07/21/2026 - 10:51 AM EDT

1

reforming_340b_to_promote_program_integrity_and_better_serve_vulnerable_populations_2026.pdf

{"Author":"Laura Baldwin","CreationDate":"2026-07-21T10:50:21-04:00","Creator":"Microsoft\u00ae Word for Microsoft 365","Keywords":"prescription drugs; 340B; affordability; drug prices; 340B drug pricing program; pharmacies; disparities; Medicaid; HRSA","ModDate":"2026-07-21T10:51:08-04:00","Producer":"Microsoft\u00ae Word for Microsoft 365","Subject":"A position paper from ACP outlining recommendations to reform the 340B Drug Pricing Program, which allows health care safety-net settings to purchase prescription drugs at deep discounts. To strengthen the 340B Program and ensure it is best serving its intended audience, reforms are needed within the program to promote transparency in how drug savings are reinvested into patient care and mandate demonstrated benefit to low-income and uninsured populations.","Title":"Reforming 340B to Promote Program Integrity and Better Serve Vulnerable Populations","Pages":1,"pdf:producer":"Microsoft\u00ae Word for Microsoft 365","pdf:keywords":"prescription drugs; 340B; affordability; drug prices; 340B drug pricing program; pharmacies; disparities; Medicaid; HRSA","xmp:creatortool":"Microsoft\u00ae Word for Microsoft 365","xmp:createdate":"2026-07-21T10:50:21-04:00","xmp:modifydate":"2026-07-21T10:51:08-04:00","xmp:metadatadate":"2026-07-21T10:51:08-04:00","xmpmm:documentid":"uuid:00CDE5E9-01F6-4281-9EF3-773AE337BA29","xmpmm:instanceid":"uuid:96066f8c-ab53-4687-9d86-184e0d4c87de","dc:format":"application\/pdf","dc:creator":"Laura Baldwin","dc:description":"A position paper from ACP outlining recommendations to reform the 340B Drug Pricing Program, which allows health care safety-net settings to purchase prescription drugs at deep discounts. To strengthen the 340B Program and ensure it is best serving its intended audience, reforms are needed within the program to promote transparency in how drug savings are reinvested into patient care and mandate demonstrated benefit to low-income and uninsured populations.","dc:subject":["prescription drugs","340B","affordability","drug prices","340B drug pricing program","pharmacies","disparities","Medicaid","HRSA"],"dc:title":"Reforming 340B to Promote Program Integrity and Better Serve Vulnerable Populations"}

2026